[Avidan, N., Panse, R., Berrih-Aknin, S., Miller, A. (2014). Genetic basis of myasthenia gravis:Acomprehensive review. J. Autoimmun., 52, 146-153.10.1016/j.jaut.2013.12.001]Search in Google Scholar
[Berrih-Aknin, S., Ruhlmann, N., Bismuth, J., Cizeron-Clairac, G., Zelman, E., Shachar, I., Dartevelle, P., de Rosbo, N. K., Le Panse, R. (2009). CCL21 overexpressed on lymphatic vessels drives thymus hyperplasia in myasthenia. Ann. Neurol., 66 (4), 521-531.10.1002/ana.21628]Search in Google Scholar
[Berrih-Aknin, S., Panse, R. (2014). Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. J. Autoimmun., 52, 90-100.10.1016/j.jaut.2013.12.011]Search in Google Scholar
[Budde, J., Morris, C. D., Gal, A. A., Mansour, K. A., Miller, J. I. (2001). Predictors of outcome in thymectomy for myasthenia gravis. Ann. Thor. Surg., 72 (1), 197-202.10.1016/S0003-4975(01)02678-9]Search in Google Scholar
[Cavalcante, P., Le Panse, R., Berrih-Aknin, S., Maggi, L., Antozzi, C., Baggi, F., Bernasconi, P., Mantegazza, R. (2011). The thymus in myasthenia gravis: Site of ‘innate autoimmunity’? Muscle & Nerve, 44 (4), 467-484. Engels, E. A. (2010). Epidemiology of thymoma and associated malignancies. J. Thor. Oncol., 5 (10), suppl. 4, s260-265.]Search in Google Scholar
[Gronseth, G. S., Barohn, R. J. (2000). Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55 (1), 7-15.10.1212/WNL.55.1.7]Search in Google Scholar
[Huang, C. H., Hsu, H. S., Huang, B. S., Lee, H. C., Kao, K. P., Hsu, W. H., Huang, M. H. (2005). Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol. Scand., 112 (2), 108-114.10.1111/j.1600-0404.2005.00424.x16008537]Search in Google Scholar
[Jaretzki, A., Barohn, R. J., Ernstoff, R. M., Kaminski, H. J., Keesey, J. C., Penn, A. S., Sanders, D. B. (2000). Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann. Thor. Surg., 70 (1), 327-334.]Search in Google Scholar
[Kawaguchi, N., Kuwabara, S., Nemoto, Y., Fukutake, T., Arimura, K., Osame, M., Hattori, T. (2007). Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin. Neurol. Neurosurg., 109 (10), 858-861.10.1016/j.clineuro.2007.08.00617904281]Search in Google Scholar
[Luo, Y., Pan, D. J., Chen, F. F., Zhu, M. H., Wang, J., Zhang, M. (2014). Effectiveness of thymectomy in nonthymomatous myasthenia gravis: A systemtic review. J. Huazhong Univ. Sci. Technol., 34 (6), 942-949.10.1007/s11596-014-1378-x25480595]Search in Google Scholar
[Lynch, H. E., Goldberg, G. L., Chidgey, A., Van den Brink, M., Boyd, R., Sempowski, G. D. (2009). Thymic involution and immune reconstitution. Trends Immunol., 30 (7), 366-373.10.1016/j.it.2009.04.003275085919540807]Search in Google Scholar
[Marx, A., Muller-Hermelink, H., Strobel, P. (2003). The role of thymomas in the development of myasthenia gravis. Ann. NY Acad. Sci., 998, 223-236.10.1196/annals.1254.02514592880]Search in Google Scholar
[Marx, A., Willcox, N., Leite, M. I., Chuang, W. Y., Schalke, B., Nix, W., Ströbel, P. (2010). Thymoma and paraneoplastic myasthenia gravis. Autoimmunity, 44 (5-6), 413-27.10.3109/08916930903555935]Search in Google Scholar
[Meriggioli, M. N., Sanders, D. B. (2009). Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. Lancet Neurol., 8 (5), 475-490.10.1016/S1474-4422(09)70063-8]Search in Google Scholar
[Muller-Hermelink, H., Marx, A. (1999). Pathological aspects of malignant and benign thymic disorders. Ann. NY Acad. Sci., 2, 5-14.]Search in Google Scholar
[Steinmann, G. G., Klaus, B., Müller-Hermelink, H. K. (1985). The involution of the ageing human thymic epithelium is independent of puberty. Scand. J. Immunol., 22 (5), 563-575.10.1111/j.1365-3083.1985.tb01916.x4081647]Search in Google Scholar